Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shoji Kaku is active.

Publication


Featured researches published by Shoji Kaku.


Reproductive Biomedicine Online | 2012

Successful delivery following ICSI with macrocephalic sperm head syndrome: a case report.

Yoshihiko Shimizu; Fuminori Kiumura; Shoji Kaku; Mika Izuno; Keiji Tomita; Dean Thumkeo; Takashi Murakami

This article reports a case of macrocephalic sperm head syndrome, which is defined as the presence of a very high percentage of spermatozoa with enlarged heads and multiple flagellae, together with detailed morphological analysis. After a couple presented with infertility, sperm analysis showed severe teratozoospermia and almost all of the spermatozoa had macrocephaly with multiple tails. The morphological analysis revealed that most of the sperm heads contained several nuclei and had a similar number of tails as that of nuclei. However, detailed analysis revealed that there were a very few spermatozoa with an almost normal morphology. After genetic counselling, intracytoplasmic sperm injection was performed using a few spermatozoa that had an almost normal morphology, resulting in pregnancy and successful delivery. Even in macrocephalic sperm head syndrome, which may be caused by meiotic division failure, pregnancy is possible if some spermatozoa with almost normal morphology can be utilized, although there may be genetic risks.


Journal of Obstetrics and Gynaecology Research | 2011

Long-term cumulative pregnancy rate in women with unexplained infertility after laparoscopic surgery followed by in vitro fertilization or in vitro fertilization alone

Yoshihiko Shimizu; Wakasa Yamaguchi; Akiko Takashima; Shoji Kaku; Nobuyuki Kita; Takashi Murakami

Aims:  Laparoscopy has been performed in women with unexplained infertility, but the recent trend is to commence in vitro fertilization (IVF) without prior laparoscopy. The aim of this study was to determine whether or not laparoscopic surgery is necessary for these patients.


Journal of Obstetrics and Gynaecology Research | 2012

A case of serous endometrial intraepithelial carcinoma with p53 positivity for six years.

Shoji Kaku; Takuya Moriya; Norichika Ushioda; Yuichiro Nakai; Koichiro Shimoya; Takafumi Nakamura

A 69‐year‐old postmenopausal woman was referred because she had been taking tamoxifen for four years. Tissues obtained by endometrial curettage were immunopositive for p53, but there was no definite malignancy. At age 73, cytology again showed abnormalities, so we repeated complete endometrial curettage. Again, there was no malignancy, but p53 immunostaining was widely positive. At age 75, hysterectomy was performed because cytological examination showed increasingly abnormal findings and the patient opted for surgery. In the resected uterus, endometrial glands were replaced by malignant cells resembling papillary serous carcinoma cells with high‐grade nuclei, but there was no stromal or myometrial invasion. The pathological diagnosis was intraepithelial serous endometrial carcinoma. This is a rare case because we could follow the patient for 6 years by endometrial cytology or endometrial curettage and we observed gradual transformation into endometrial intraepithelial carcinoma.


Fertility and Sterility | 2010

Three-dimensional computed tomography combined with hysterosalpingography is useful for both diagnosis and treatment of iatrogenic diverticulum of the uterus

Yoshihiko Shimizu; Hitoshi Kitahara; Wakasa Yamaguchi; Shoji Kaku; Nobuyuki Kita; Takashi Murakami

A woman presented with vaginal bleeding after myomectomy. Ultrasonography, magnetic resonance imaging (MRI), and three-dimensional computed tomography (CT) combined with hysterosalpingography (HSG) revealed an iatrogenic diverticulum of the uterus. The three-dimensional CT combined with HSG images were very useful for subsequent surgery.


Experimental Animals | 2018

Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model of cisplatin-induced ovarian gonadotoxicity

Yuji Tanaka; Fuminori Kimura; Luyi Zheng; Shoji Kaku; Akie Takebayashi; Kyoko Kasahara; Shunichiro Tsuji; Takashi Murakami

This study aimed to evaluate the protective effect of everolimus, a mechanistic target of rapamycin (mTOR) inhibitor, on cisplatin chemotherapy-induced ovarian toxicity. Eighty sexually mature, virgin, female, 7-week-old C57BL/6J mice were divided into four groups: control, cisplatin (Cis), everolimus (mTORi), and everolimus plus cisplatin (mTORi+Cis). Mice in the Cis and mTORi+Cis groups were intraperitoneally injected with 2 mg/kg of cisplatin for 15 d. Mice in the mTORi and mTORi+Cis groups were orally administered 2.5 mg/kg of everolimus for 29 d, from one week before the first cisplatin injection to one week after the last cisplatin injection. Histological examinations were performed 24 h after the last everolimus administration. The primordial, primary, and antral follicles were significantly depleted in the Cis group compared with that in the control group, confirming the gonadotoxicity of cisplatin. The number of primordial, secondary, and antral follicles was significantly higher in the mTORi+Cis group than in the Cis group, thereby displaying the effect of mTORi-treatment on ovarian protection. Primordial, secondary, and antral follicle counts were similar in the mTORi+Cis and the control groups. The results of this study indicate a protective effect of an mTOR inhibitor against cisplatin chemotherapy-induced gonadotoxicity in the ovarian reserve in an in vivo mouse model.


Obstetrics and Gynecology International | 2015

Management of Fetal Growth Arrest in One of Dichorionic Twins: Three Cases and a Literature Review

Shoji Kaku; Fuminori Kimura; Takashi Murakami

Progressive fetal growth restriction (FGR) is often an indication for delivery. In dichorionic diamniotic (DD) twin pregnancy with growth restriction only affecting one fetus (selective fetal growth restriction: sFGR), the normal twin is also delivered prematurely. There is still not enough evidence about the optimal timing of delivery for DD twins with sFGR in relation to discordance and gestational age. We report three sets of DD twins with sFGR (almost complete growth arrest affecting one fetus for ≥2 weeks) before 30 weeks of gestation. The interval from growth arrest to delivery was 21–24 days and the discordance was 33.7–49.8%. A large-scale study showed no difference of overall mortality or the long-term outcome between immediate and delayed delivery for FGR, while many studies have identified a risk of developmental delay following delivery of the normal growth fetus before 32 weeks. Therefore, delivery of DD twins with sFGR should be delayed if the condition of the sFGR fetus permits in order to increase the gestational age of the normal growth fetus.


Experimental and Therapeutic Medicine | 2010

Neoadjuvant intraarterial chemotherapy for stage IIB-IIIB cervical cancer in Japanese women.

Shoji Kaku; Kentaro Takahashi; Yoshitaka Murakami; Shirou Wakinoue; Tetsuya Nakagawa; Yoshihiko Shimizu; Nobuyuki Kita; Yoichi Noda; Takashi Murakami


BMC Pregnancy and Childbirth | 2016

Management of ureteral stenting for postrenal failure during pregnancy after ureteral reimplantation: a case report

Yutaka Yoneoka; Shoji Kaku; Shunichiro Tsuji; Hiroto Yamashita; Takashi Inoue; Fuminori Kimura; Takashi Murakami


Tohoku Journal of Experimental Medicine | 2014

Exaggerated Placental Site, Consisting of Implantation Site Intermediate Trophoblasts, Causes Massive Postpartum Uterine Hemorrhage: Case Report and Literature Review

Akie Takebayashi; Fuminori Kimura; Akiyoshi Yamanaka; Akimasa Takahashi; Shunichiro Tsuji; Tetsuo Ono; Shoji Kaku; Nobuyuki Kita; Kentaro Takahashi; Hidetoshi Okabe; Takashi Murakami


川崎医学会誌 | 2011

A case of extremely rare ovarian tumor: Primary ovarian adenomyoma

Shoji Kaku; Takuya Moriya; Naoki Kanomata; Tsuyoshi Ishida; Yangsil Chang; Norichika Ushioda; Yuichiro Nakai; SHIMOYAKoichiro; Takafumi Nakamura

Collaboration


Dive into the Shoji Kaku's collaboration.

Top Co-Authors

Avatar

Takashi Murakami

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Kentaro Takahashi

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Nobuyuki Kita

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Yoshihiko Shimizu

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Fuminori Kimura

University of Massachusetts Amherst

View shared research outputs
Top Co-Authors

Avatar

Shunichiro Tsuji

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Akie Takebayashi

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Akiko Takashima

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Tetsuya Nakagawa

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Akimasa Takahashi

Shiga University of Medical Science

View shared research outputs
Researchain Logo
Decentralizing Knowledge